| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine [I. F. T.] and Medical Biophysics [K. J. N., I. F. T.], Ontario Cancer Institute and University of Toronto, Toronto, Ontario M4X 1K9, Canada
The environment of cells within solid tumors is known to be acidic relative to that in normal tissue, and the viability of tumor cells may depend on mechanisms which maintain intracellular pH (pHi) above the extracellular pH (pHe). We have assessed therefore the toxicity in vitro of the proton ionophore carbonylcyanide-3-chlorophenylhydrazone (CCCP), since this agent has been reported to be capable of transporting H+ equivalents through artificial lipid bilayers and mitochondrial membranes. CCCP was toxic to the human bladder carcinoma cell line MGH-U1 and to the murine mammary sarcoma cell line EMT-6 only at pHe < 6.5. CCCP transported H+ equivalents through cell membranes at physiological (7.35) and low pHe (6.20). Cell lines were found to have steady-state pHi values approximately 0.1 to 0.2 pH units above pHe at pHe < 6.50. Addition of CCCP led to a decrease in steady-state pHi values as compared to untreated cells at pHe < 6.50, whereas there was no apparent effect of CCCP on steady-state pHi values at pHe > 6.50. The CCCP-induced reduction in steady-state pHi combined with the uncoupling of oxidative phosphorylation by CCCP appeared to be the major mechanisms leading to cell death at pHe < 6.50. The toxicity of CCCP under acidic conditions was enhanced by amiloride and 4,4'-diisothiocyanostilbene-2,2-disulfonic acid, agents which are known to inhibit membrane-based ion exchange mechanisms which regulate pHi under acidic conditions. When both agents were combined with CCCP, cell killing was observed at pHe < 7.30. Our results suggest that mechanisms which regulate pHi under acidic conditions which occur in solid tumors may represent targets for new forms of tumor-specific therapy.
1 This study was supported by a research grant from the Medical Research Council of Canada.
2 To whom requests for reprints should be addressed.
Received 2/28/89. Revised 5/12/89. Accepted 5/18/89.
This article has been cited by other articles:
![]() |
Y. Shimoyama, Y. Akihara, D. Kirat, H. Iwano, K. Hirayama, Y. Kagawa, T. Ohmachi, K. Matsuda, M. Okamoto, T. Kadosawa, et al. Expression of Monocarboxylate Transporter 1 in Oral and Ocular Canine Melanocytic Tumors Vet. Pathol., July 1, 2007; 44(4): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vermeulen, M. Giordano, A. S. Trevani, C. Sedlik, R. Gamberale, P. Fernandez-Calotti, G. Salamone, S. Raiden, J. Sanjurjo, and J. R. Geffner Acidosis Improves Uptake of Antigens and MHC Class I-Restricted Presentation by Dendritic Cells J. Immunol., March 1, 2004; 172(5): 3196 - 3204. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. McLean, J. Roscoe, N. K. Jorgensen, F. A. Gorin, and P. M. Cala Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes Am J Physiol Cell Physiol, April 1, 2000; 278(4): C676 - C688. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Poulin, M. Lessard, and C. Zhao Inorganic Cation Dependence of Putrescine and Spermidine Transport in Human Breast Cancer Cells J. Biol. Chem., January 27, 1995; 270(4): 1695 - 1704. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |